Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Consogno

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Bollettino Dell'Istituto Sieroterapico Milanese|March 1, 1976
Complement profile and anticomplementary potential in mixed cryoglobulinemiaP Casali, P Borzini, G Consogno, et al.
Acta Haematologica|January 1, 1975
Anti-IgA antibodies in two brothers with selective serum IgA deficiencyF Invernizzi, G Balestrieri, G Consogno, et al.
Cancer Immunology, Immunotherapy : CII|September 1, 1994
Reversible anergy in circulating lymphocytes of cancer patients during interleukin-2 therapyE Clementi, E Bucci, G Citterio, et al.
Bollettino Dell'Istituto Sieroterapico Milanese|November 20, 1975
[Immune complexes DNA-anti-DNA during the course of mixed cryoglobulinemia]G Balestrieri, A Tincani, P S Riboldi, et al.
The Journal of Surgical Research|May 1, 1996
Thymopentin modulates Th1 and Th2 cytokine response and host survival in experimental injuryM Braga, L Gianotti, O Gentilini, et al.
Clinical Immunology and Immunopathology|August 1, 1995
Serum levels of soluble cell adhesion molecules (ICAM-1, VCAM-1, E-selectin) and of cytokine TNF-alpha increase during interleukin-2 therapyC Fortis, L Galli, G Consogno, et al.
Acta Haematologica|January 1, 1974
Nature of the antigammaglobulin activity in cryoglobulinemic disordersG Balestrieri, F Invernizzi, G Consogno, et al.
Cancer Letters|June 24, 1996
Increased interleukin-10 serum levels in patients with solid tumoursC Fortis, M Foppoli, L Gianotti, et al.
Cancer Research|April 18, 2001
Inhibition of caspases maintains the antineoplastic function of gammadelta T cells repeatedly challenged with lymphoma cellsM Ferrarini, G Consogno, P Rovere, et al.
Cancer Research|May 27, 1999
Major histocompatibility complex class I restricted cytotoxic T cells specific for natural melanoma peptides recognize unidentified shared melanoma antigen(s)M A Imro, S Manici, V Russo, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Bollettino Dell'Istituto Sieroterapico Milanese|March 1, 1976
Complement profile and anticomplementary potential in mixed cryoglobulinemiaP Casali, P Borzini, G Consogno, et al.
Acta Haematologica|January 1, 1975
Anti-IgA antibodies in two brothers with selective serum IgA deficiencyF Invernizzi, G Balestrieri, G Consogno, et al.
Cancer Immunology, Immunotherapy : CII|September 1, 1994
Reversible anergy in circulating lymphocytes of cancer patients during interleukin-2 therapyE Clementi, E Bucci, G Citterio, et al.
Bollettino Dell'Istituto Sieroterapico Milanese|November 20, 1975
[Immune complexes DNA-anti-DNA during the course of mixed cryoglobulinemia]G Balestrieri, A Tincani, P S Riboldi, et al.
The Journal of Surgical Research|May 1, 1996
Thymopentin modulates Th1 and Th2 cytokine response and host survival in experimental injuryM Braga, L Gianotti, O Gentilini, et al.
Clinical Immunology and Immunopathology|August 1, 1995
Serum levels of soluble cell adhesion molecules (ICAM-1, VCAM-1, E-selectin) and of cytokine TNF-alpha increase during interleukin-2 therapyC Fortis, L Galli, G Consogno, et al.
Acta Haematologica|January 1, 1974
Nature of the antigammaglobulin activity in cryoglobulinemic disordersG Balestrieri, F Invernizzi, G Consogno, et al.
Cancer Letters|June 24, 1996
Increased interleukin-10 serum levels in patients with solid tumoursC Fortis, M Foppoli, L Gianotti, et al.
Cancer Research|April 18, 2001
Inhibition of caspases maintains the antineoplastic function of gammadelta T cells repeatedly challenged with lymphoma cellsM Ferrarini, G Consogno, P Rovere, et al.
Cancer Research|May 27, 1999
Major histocompatibility complex class I restricted cytotoxic T cells specific for natural melanoma peptides recognize unidentified shared melanoma antigen(s)M A Imro, S Manici, V Russo, et al.
Pageof 2